IDENIX PHARMACEUT IDIX (NASDAQ)

$ 4.45
15:29
Sponsored by
Click here!
Change: -0.88 (-16.51%)
Volume: 144,869

Avg. Volume: 253348
P/E Ratio: 0
EPS (Annual): -1.55
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 56,340
Institutional Shareholders: 24.58%
Last: 4.45
Change: -0.88 (-16.51%)
Prev. Close: 5.33
Open: 5.40
Day's Range: 4.45 - 5.40
52wk Range: 2.10 - 10.10
Market Value: 301,290
Beta: -.21
12-month EPS Change: -36.08%
Total Return Last 12 Months: +104.21%
Total Return Last 3 Years: -696.17%
Total Return Last 5 Years: -60.37%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on IDIX
Alert me Subscribe

Vertex falls on data for Schering hepatitis drug

(NEW YORK)Shares of Vertex Pharmaceuticals Inc. fell Monday after Schering-Plough Corp. reported positive data from a trial of a hepatitis C drug, showing it could be a strong competitor to ...READ MORE
Aug 04, 2008 6:52PM
Keywords: VRTX, SGP, JNJ, MRK, ITMN, IDIX

Earnings roundup: China bank ICBC, Scandinavian carrier SAS

Among the earnings stories for Tuesday, April 29, from AP Financial News: BEIJING (AP) _ Industrial & Commercial Bank of China Ltd., the nation's biggest commercial lender, sai...READ MORE
Apr 29, 2008 3:33PM
Keywords: IDIX, ALGT, CGNX

Idenix loss widens on lower research and development payback

(CAMBRIDGE, Mass.)Biopharmaceutical company Idenix Pharmaceuticals Inc. said Tuesday its first-quarter loss widened because of a decrease in reimbursements for research and development costs and a l...READ MORE
Apr 29, 2008 1:01PM
Keywords: IDIX, NVS

Sector Snap: Hepatitis C drugs in focus at conference

(NEW YORK)Shares in Vertex Pharmaceuticals Inc. slid Wednesday while Idenix Pharmaceuticals Inc. gained ground on a mix of study data for the their developing hepatitis C drug candidates.READ MORE
Apr 23, 2008 12:54PM
Keywords: VRTX, IDIX, SGP, ITMN, JNJ

Susquehanna Upgrades Idenix Pharma

(NEW YORK)Shares of Idenix Pharmaceuticals Inc. edged higher Friday morning, as a Susquehanna Financial Group analyst praised the company's strong cash position and "promising" early-stage d...READ MORE
Jan 11, 2008 8:00PM
Keywords: IDIX, NVS

Outlook Roundup: SonoSite, Barrier

Among the earnings projection stories for Monday, Jan. 7, from AP Financial News: BOTHELL, Wash. (AP) _ Ultrasound systems maker SonoSite Inc. said Monday preliminary calculations ...READ MORE
Jan 07, 2008 2:36PM
Keywords: SONO, BTRX, IDIX, PTEC, BIIB

Idenix Pharma Backs Year-End Cash View

(SAN FRANCISCO)Hepatitis C and HIV drug developer Idenix Pharmaceuticals Inc. on Monday reaffirmed it expects to report ending fiscal 2007 with between $100 million and $110 million of cash, cash...READ MORE
Jan 07, 2008 12:41PM
Keywords: IDIX
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN -5.00 51.61
GILEAD SCIENCES -13.90 41.32
GENENTECH INC +2.90 79.12
CELGENE CP -17.10 57.80
BIOGEN IDEC INC -36.10 45.19